Abitec Corporation

Activities: Ingredients Drug Delivery Pharmaceutical Nutraceutical

Trending Articles

  1. Johnson & Johnson to bolster neuroscience portfolio with $14.6bn Intra-Cellular Therapies acquisition Through this potential acquisition, Johnson & Johnson will add schizophrenia and bipolar drug Caplyta to its portfolio, as well as a range of clinical candidates designed to...
  2. Lonza and Iconovo collaborate to develop intranasal biologic for obesity The two will aim to create an effective and stable inhaled formulation that can be used to treat obesity without the need for frequent injections
  3. Teva Pharmaceuticals, Klinge Pharma and Formycon join forces to commercialise Eylea biosimilar FYB203, which will be marketed under the name AHZANTIVE®3 if approved by the EMA, will be commercialised by Teva Pharmaceuticals in the majority of Europe and Israel
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Revolutionising drug delivery and advancing sustainability Capsule innovation and 3D printing will transform pharma for a future of precision and ethical solutions
  5. MM Pharma showcases its secondary packaging solutions at Pharmapack Europe 2025 Visitors to booth J85 can chat with technical experts about pharmaceutical packaging challenges and requirements, as well as how MM Pharma can help with their secondary...

Upcoming event

Pharmapack

22 – 23 January 2025 | Exhibition | Paris, France See all

Related Content

Manufacturing

ABITEC Corporation bolsters its high-purity lipid offerings for LNP therapeutics

The company can provide cGMP-grade lipids from a mg to a kg scale, assisting the production of advanced LNP therapeutics, including vaccines
Ingredients

DKSH signs exclusive distribution agreement with Abitec

The ingredients and specialty chemicals distributor has been selected to exclusively distribute a lipid excipient and nutritional supplement range in Thailand, Spain and Portugal
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Ingredients see a drive for more science

The need for greater solubility and bioavailability of new medicines, as well as increasing manufacturing efficiencies are driving developments in ingredients. Susan Birks reports on the latest trends
Subscribe now